By Benjamin Chiou
Date: Monday 02 Jun 2025
(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to the Nasdaq.
By Iain Gilbert
Date: Monday 02 Jun 2025
(Sharecast News) - Drugmaker GSK revealed on Monday that a new drug application for its linerixibat asset had been accepted for review by the US Food and Drug Administration for use in cholestatic pruritus patients with primary biliary cholangitis.
By Iain Gilbert
Date: Friday 30 May 2025
(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.
Price | 21,228.55 |
Closing Price Change | 545.13 |
% Change | 2.64 % |
30-May-25 Close | 21,228.55 |
You are here: research